SNHG17 and gastric cancer: Moreover, we showed that knocking down SNHG17 reduced SNORA71B in NSCLC, gastric cancer, and colorectal cancer cell lines (A549, MGC-803, and DLD1), in which SNHG17 was reported to exert oncogenic functions by former studies16,34,35 (Supplementary Fig. 1b).